Viemed Healthcare (VMD) Net Income towards Common Stockholders (2018 - 2026)

Viemed Healthcare (VMD) has reported Net Income towards Common Stockholders for 9 consecutive years, with $2.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Income towards Common Stockholders fell 10.77% year-over-year to $2.9 million; the trailing twelve-month figure through Jun 2026 stood at $15.0 million (up 5.02% YoY), and the FY2025 full-year result was $15.4 million, up 34.77% from the prior year.
• Net Income towards Common Stockholders advanced to $2.9 million in Q2 2026 per VMD's latest filing, from $2.7 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $5.8 million in Q4 2025 and bottomed at $967000.0 in Q2 2022.
• Historically, Net Income towards Common Stockholders has averaged $2.7 million across 5 years, with a median of $2.7 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders slumped 41.03% in 2022, then soared 176.68% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at $2.4 million in 2022, then surged by 42.62% to $3.5 million in 2023, then climbed by 27.24% to $4.4 million in 2024, then surged by 31.46% to $5.8 million in 2025, then slumped by 50.14% to $2.9 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $2.9 million, $2.7 million, and $5.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.